TY - JOUR
T1 - Can precision medicine be integrated into routine therapeutic decisions at the bedside of patients?
AU - Lemaitre, Florian
AU - Florentin, Virginie
AU - Blin, Olivier
AU - Bayle, Arnaud
AU - Benito, Sylvain
AU - Chauny, Jean Vannak
AU - Galaup, Ariane
AU - Korchagina, Daria
AU - Lang, Marie
AU - Le Tourneau, Christophe
AU - Pelloux, Hervé
AU - Picard, Nicolas
AU - Guilhaumou, Romain
N1 - Publisher Copyright:
© 2023
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Therapeutic strategies are shifting from a “one-size-fits-all” population-based approach to a stratified approach targeting groups with similar characteristics, or even individuals, tailoring treatments to the unique characteristics of each patient. Since such strategies rely on increasingly complex knowledge and healthcare technologies, along with an understanding of the tools of precision medicine, the appropriate dissemination and use of these strategies involves a number of challenges for the medical community. Having evaluation methodologies that have been jointly designed with the institutional, industrial, academic stakeholders, and also patients, like streamlining the processes and externally validating performances, could enhance the relevance of the “evaluation” aspect of precision medicine. Creating a network of expert precision-medicine centers and ensuring that precision-medicine procedures are reimbursed by social security would guarantee fair and sustainable access. Finally, training healthcare professionals, creating interfaces between precision-medicine expert centers and primary care professionals as well as patients, and integrating individual patient data into medical records are all key drivers that will enable information from precision-medicine to be made available and guarantee the proper use of these approaches.
AB - Therapeutic strategies are shifting from a “one-size-fits-all” population-based approach to a stratified approach targeting groups with similar characteristics, or even individuals, tailoring treatments to the unique characteristics of each patient. Since such strategies rely on increasingly complex knowledge and healthcare technologies, along with an understanding of the tools of precision medicine, the appropriate dissemination and use of these strategies involves a number of challenges for the medical community. Having evaluation methodologies that have been jointly designed with the institutional, industrial, academic stakeholders, and also patients, like streamlining the processes and externally validating performances, could enhance the relevance of the “evaluation” aspect of precision medicine. Creating a network of expert precision-medicine centers and ensuring that precision-medicine procedures are reimbursed by social security would guarantee fair and sustainable access. Finally, training healthcare professionals, creating interfaces between precision-medicine expert centers and primary care professionals as well as patients, and integrating individual patient data into medical records are all key drivers that will enable information from precision-medicine to be made available and guarantee the proper use of these approaches.
KW - Artificial intelligence
KW - Genomic
KW - Individualisation
KW - Precision medicine
KW - Stratification
UR - http://www.scopus.com/inward/record.url?scp=85179490108&partnerID=8YFLogxK
U2 - 10.1016/j.therap.2023.11.007
DO - 10.1016/j.therap.2023.11.007
M3 - Article
AN - SCOPUS:85179490108
SN - 0040-5957
VL - 79
SP - 13
EP - 22
JO - Therapie
JF - Therapie
IS - 1
ER -